Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 01-2001 | 12-2000 | 10-2000 | 09-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,670 | -1,160 | -1,160 | -760 | -760 |
| Depreciation Amortization | 70 | 50 | 50 | 30 | 30 |
| Other Working Capital | -140 | -100 | -100 | 40 | 40 |
| Other Operating Activity | 210 | 120 | 120 | 130 | 130 |
| Operating Cash Flow | $-1,530 | $-1,090 | $-1,090 | $-560 | $-560 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -240 | -180 | -180 | -160 | -160 |
| Other Investing Activity | -70 | -30 | -30 | -40 | -40 |
| Investing Cash Flow | $-310 | $-210 | $-210 | $-200 | $-200 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 640 | 530 | 530 | 400 | 400 |
| Financing Cash Flow | $640 | $530 | $530 | $400 | $400 |
| Beginning Cash Position | 5,460 | 5,460 | 5,460 | 5,460 | 5,460 |
| End Cash Position | 4,250 | 4,690 | 4,690 | 5,090 | 5,090 |
| Net Cash Flow | $-1,210 | $-770 | $-770 | $-360 | $-360 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,530 | -1,090 | -1,090 | -560 | -560 |
| Free Cash Flow | -1,530 | -1,090 | -1,090 | -560 | -560 |